Chemed Co. (NYSE:CHE) Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Chemed Co. (NYSE:CHE) by 36.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 3,406 shares of the company’s stock after acquiring an additional 914 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Chemed were worth $1,804,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. State Street Corp raised its holdings in Chemed by 0.8% in the 3rd quarter. State Street Corp now owns 464,354 shares of the company’s stock valued at $279,063,000 after acquiring an additional 3,564 shares during the last quarter. Geode Capital Management LLC raised its holdings in Chemed by 4.9% in the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock valued at $201,820,000 after acquiring an additional 15,791 shares during the last quarter. Boston Trust Walden Corp raised its holdings in Chemed by 10.0% in the 4th quarter. Boston Trust Walden Corp now owns 242,172 shares of the company’s stock valued at $128,303,000 after acquiring an additional 22,105 shares during the last quarter. FMR LLC raised its holdings in Chemed by 23.8% in the 3rd quarter. FMR LLC now owns 238,616 shares of the company’s stock valued at $143,401,000 after acquiring an additional 45,917 shares during the last quarter. Finally, Copeland Capital Management LLC raised its holdings in Chemed by 16.8% in the 4th quarter. Copeland Capital Management LLC now owns 151,623 shares of the company’s stock valued at $80,330,000 after acquiring an additional 21,834 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Stock Up 1.7 %

CHE stock opened at $608.63 on Tuesday. The company has a market cap of $8.91 billion, a price-to-earnings ratio of 30.75, a PEG ratio of 2.15 and a beta of 0.43. The business has a fifty day simple moving average of $561.91 and a 200-day simple moving average of $564.94. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $653.75.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were given a dividend of $0.50 per share. The ex-dividend date was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. Chemed’s dividend payout ratio (DPR) is 10.05%.

Insider Buying and Selling

In other Chemed news, VP Brian C. Judkins purchased 145 shares of the firm’s stock in a transaction that occurred on Monday, December 30th. The stock was purchased at an average cost of $519.50 per share, with a total value of $75,327.50. Following the transaction, the vice president now owns 1,678 shares in the company, valued at approximately $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now directly owns 102,679 shares of the company’s stock, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research firms have recently commented on CHE. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada upped their price objective on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a report on Friday.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.